Back to the search results

Evangelisches Krankenhaus Düsseldorf

Evangelisches Krankenhaus Düsseldorf
Evangelisches Krankenhaus Düsseldorf

Kirchfeldstr. 40
40217 Düsseldorf

Phone: 0211-9190
Mail: ed.frodlesseud-kve@gnutlawrev

  • Number of beds: 513
  • Number of specialist departments: 15
  • Number of inpatient cases: 22.596
  • Number of partial inpatient cases: 254
  • Number of outpatient cases: 60.788
  • Hospital owners: Stiftung Evangelisches Krankenhaus Düsseldorf
  • Type of provider: freigemeinnützig
External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
Quantity performed 104
Exception? No exception
Quantity performed 30
Exception? No exception
Quantity performed 56
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 56
Quantity forecast year: 56
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 30
Quantity forecast year: 35
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 17
Quantity forecast year: 19
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 104
Quantity forecast year: 131
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
No. Explanation
CQ05 Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1
CQ01 Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: yes
Number Group
238 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
72 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
26 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

  • aktuell in Verabschiedung
Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission
  • Zubereitung durch pharmazeutisches Personal
  • Elektronisches Bestellsystem und automatisierte Zusammenstellung, gesicherter Transport
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Prof. Dr. med. Horst Neuhaus (Innere Medizin), Fr. Dr. Carolin Nestle-Krämling (Gynäkologie), Fr. Prof. Dr. med Monika Gappa (Kinderklinik), Prof. Dr. Werner Hartwig (Chirurgie), Prof. Dr. Christian Meyer (Kardiologie)

Explanation

Ausbildung von Famulanten und Studenten im Praktischen Jahr der Heinrich-Heine-Universität-Düsseldorf

Explanation

Prof. Dr. med. Horst Neuhaus (Innere Medizin) , Prof. Dr. med. Christian Meyer (Kardiologie), Prof. Dr. med. Monika Gappa (Kinderklinik), Prof. Thomas Lauenstein (Radiologie)

Explanation

Prof. Dr. med. Werner Hartwig (Chirurgie)

Explanation

Prof. Dr. med. Christian Meyer (Kardiologie), Prof. Dr. med. Thomas Lauenstein (Radiologie), Dr. Gregor Wolf (HNO-Klinik), Prof. Dr. med. Monika Gappa (Kinderklinik), Prof. Horst Neuhaus (Innere Medizin), PD Dr. Torsten Beyna (Innere Medizin), PD Dr. Olaf Boehm (Anästhesie)

Explanation

Priv.-Doz. Dr. med. René Chatelain, Prof. Dr. med. Werner Hartwig, Prof. Dr. med. Thomas Lauenstein, Prof. Dr. med. Horst Neuhaus, Prof. Dr. med. Monika Gappa, PD Dr. Olaf Boehm, Prof. Dr. med. Christian Meyer

Explanation

IWF Düsseldorf, Helmholz Institut /Klinik für Kinder-u. Jugendmedizin, Institut für Neuro- u. Sinnesphysiologie, HHU Düsseldorf, Klinik für Kardiologie, Pneumologie u. Angiologie, Universitätsklinikum Düsseldorf, Kooperation mit HNO-Klinik-Universitätsklinikum Düsseldorf

Explanation

Training in other healing professions
Comment

1 Ausbildungsplatz pro Jahr

Comment

135 Ausbildungsplätze (Generalistische Ausbildung ab 2022)

Comment

100 Ausbildungsplätze. Zertifizierung und Rezertifizierung nach ISQ.

Comment

75 Ausbildungsplätze

Comment

40 Ausbildungsplätze

Comment

20 Ausbildungsplätze

Comment

3 Ausbildungsplätze pro Jahr

Klaus Wiegand

Patientenfürsprecher

Kirchfeldstr. 40
40217 Düsseldorf

Phone: 0211 -919-0
Mail: ed.frodlesseud-kve@rehcerpsreufnetneitap

Klaus Wiegand

Patientenfürsprecher

Kirchfeldstr. 40
40217 Düsseldorf

Phone: 0211 -919-0
Mail: ed.frodlesseud-kve@rehcerpsreufnetneitap

Dieter Gurschke

Leiter Innere Verwaltung

Kirchfeldstr. 40
40217 Düsseldorf

Phone: 0211 -919-2001
Mail: ed.frodlesseud-kve@ekhcsrug.reteid

Christiane Koletzki

QMB

Kirchfeldstr. 40
40217 Düsseldorf

Phone: 0211 -919-2140
Mail: ed.frodlesseud-kve@ikztelok.enaitsirhc

Prof. Dr. Thomas Lauenstein

Ärztlicher Direktor, Chefarzt der Radiologie

Kirchfeldstr. 40
40217 Düsseldorf

Phone: 0211 -919-1055
Mail: ed.frodlesseud-kve@eigoloidar

Renata Plis-Zeligowska

Schwerbehindertenbeauftrage

Kirchfeldstr. 40
40217 Düsseldorf

Phone: 0211 -919-481858
Mail: ed.frodlesseud-kve@akswogileZ-silP.ataneR

Sandra Cremer

Pflegedirektorin

Kirchfeldstr. 40
40217 Düsseldorf

Phone: 0211 -919-4006
Mail: ed.frodlesseud-kve@ldp

Dipl.-Oec. Klaus Peter Taschner

Vorstand

Kirchfeldstr. 40
40217 Düsseldorf

Phone: 0211 -919-2003
Mail: ed.frodlesseud-kve@gnutlawrev

Dipl.-Oec. Klaus Peter Taschner

Vorstand

Kirchfeldstr. 40
40217 Düsseldorf

Phone: 0211 -919-2003
Mail: ed.frodlesseud-kve@gnutlawrev

Prof. Dr. Thomas Lauenstein

Ärztlicher Direktor, Chefarzt der Radiologie

Kirchfeldstr. 40
40217 Düsseldorf

Phone: 0211 -919-1055
Mail: ed.frodlesseud-kve@eigoloidar

IK: 260510132

Location number: 773140000

Old location number: 773140000